STAT3 and breast cancer: Consistently, constitutive activation of STAT3 was demonstrated in a wide variety of human tumors, including hematological malignancies, as well as solid tumors, such as head and neck, lung, gastric, hepatocellular, colorectal, prostate, and breast cancers [1,2,3].